DK1408949T3 - Glycine betaine and its scope of the invention - Google Patents

Glycine betaine and its scope of the invention

Info

Publication number
DK1408949T3
DK1408949T3 DK02701110T DK02701110T DK1408949T3 DK 1408949 T3 DK1408949 T3 DK 1408949T3 DK 02701110 T DK02701110 T DK 02701110T DK 02701110 T DK02701110 T DK 02701110T DK 1408949 T3 DK1408949 T3 DK 1408949T3
Authority
DK
Denmark
Prior art keywords
scope
glycine betaine
betaine
glycine
Prior art date
Application number
DK02701110T
Other languages
Danish (da)
Inventor
Jallal Messadek
Original Assignee
Jallal Messadek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE2001/0085A external-priority patent/BE1013958A6/en
Priority claimed from US09/945,391 external-priority patent/US6855734B2/en
Application filed by Jallal Messadek filed Critical Jallal Messadek
Application granted granted Critical
Publication of DK1408949T3 publication Critical patent/DK1408949T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02701110T 2001-02-05 2002-02-04 Glycine betaine and its scope of the invention DK1408949T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
BE2001/0085A BE1013958A6 (en) 2001-02-05 2001-02-05 Pharmaceutical combination useful in the treatment of thrombosis comprises a therapeutic active agent with at least one hemorrhagic side effect and a glycine betaine
US09/945,391 US6855734B2 (en) 1999-03-02 2001-08-31 Glycine betaine and its use
BEPCT/BE01/00222 2001-12-21
PCT/BE2002/000013 WO2002062322A2 (en) 2001-02-05 2002-02-04 Glycine betaine and its use as anti-hemorrhagic agent

Publications (1)

Publication Number Publication Date
DK1408949T3 true DK1408949T3 (en) 2008-04-28

Family

ID=27159516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02701110T DK1408949T3 (en) 2001-02-05 2002-02-04 Glycine betaine and its scope of the invention

Country Status (5)

Country Link
EP (1) EP1408949B1 (en)
CA (1) CA2441948A1 (en)
DK (1) DK1408949T3 (en)
ES (1) ES2298342T3 (en)
WO (1) WO2002062322A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1015608A6 (en) 2003-07-15 2005-06-07 Messadek Jallal TREATMENT arteritis.
ES2278314T3 (en) * 2003-04-17 2007-08-01 Jallal Messadek ORAL FORMULATIONS FOR THE CONTROLLED RELEASE OF THE BETA.
WO2005011645A2 (en) * 2003-08-04 2005-02-10 Jallal Messadek Selected betaines and their uses
BE1016128A6 (en) * 2004-07-22 2006-03-07 Messadek Jallal Combination therapy
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
BRPI0610249A2 (en) 2005-04-27 2010-06-08 Jallal Messadek pharmaceutical combination or combination, pharmaceutical composition, co-crystallization process and the use of insulin or insulin analogue
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
GB2447685A (en) * 2007-03-21 2008-09-24 Nozotec Ab Haemostatic and dentifrice compositions
CL2008001640A1 (en) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Use of hydroxyproline to prepare an alloy composition intended to promote the growth of an animal, such as fish, birds and mammals.
WO2009065193A1 (en) * 2007-11-21 2009-05-28 Jallal Messadek Treatment of aspirin resistance with betaine and/or betaine enriched molasses
CN114828644A (en) 2019-12-16 2022-07-29 希尔氏宠物营养品公司 Pet food compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226386B (en) * 1988-07-08 1991-01-15 Chiesi Farma Spa MORNIFLUMATO AND ANALOGUE PREPARATION PROCEDURE.
US5876780A (en) * 1993-04-29 1999-03-02 Cultor, Ltd. Compositions for treating coccidiosis
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
JP2000143486A (en) * 1998-11-12 2000-05-23 Lion Corp Skin preparation for external use
BE1012495A3 (en) * 1999-03-02 2000-11-07 Messadek Jallal Glycine betaine-for its use antithrombotic.
BE1012546A6 (en) * 1999-03-10 2000-12-05 Messadek Jallal Betaine and its derivatives for their antithrombotic use
BE1012712A6 (en) * 1999-06-10 2001-02-06 Messadek Jallal Antithrombotic peptides

Also Published As

Publication number Publication date
CA2441948A1 (en) 2002-08-15
ES2298342T3 (en) 2008-05-16
WO2002062322A2 (en) 2002-08-15
EP1408949A2 (en) 2004-04-21
EP1408949B1 (en) 2007-12-19
WO2002062322A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
DE60212600D1 (en) AUDIOCODING AND DECODING
DK1390389T3 (en) Crypto-blocking antibodies and uses thereof
DK1637660T3 (en) Wear element and wear assembly
DK1746375T3 (en) Oxygen-fueled combustion system and uses thereof
DK1417175T3 (en) SUBSTITUTED DIHYDRO-3-HALO-1H-PYRAZOL-5-CARBOXYLATES AND PREPARATION AND USE THEREOF
NO20040139L (en) N- (3-amino-2-hydroxy-propyl) substituted alkylamido compounds
PT1411764E (en) Close
DE10196542T1 (en) metal seal
DE60227134D1 (en) joint assembly
NO20033854L (en) N-but-3-enyl-norbuprenorphine and methods of use
DK1408949T3 (en) Glycine betaine and its scope of the invention
DE50200615D1 (en) gemini
DE60208700D1 (en) SCHÄLGERÄT AND ASSOCIATED PROCEDURES
BR0207810A (en) peptide deformylase inhibitors
DE60222336D1 (en) strapper
DE50200466D1 (en) Balun
ITMI20010954A0 (en) IODURATION PROCEDURE
DE50213801D1 (en) JOINT
NO20032963L (en) peptide
GB0110996D0 (en) Improved bridge joint
DE60228171D1 (en) metal seal
DE50201194D1 (en) strapper
DE60222567D1 (en) glutaminase
DE60219418T8 (en) SILANOLLPHENOL AND NAPHTHOLE
DE60203127D1 (en) ABSOLUTE WINKELGEBER